Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
---|---|---|---|
USD 7,905.45 million | USD 11,004.78 million | 4.22% | 2022 |
The global cattle healthcare market size was worth around USD 7,905.45 million in 2022 and is predicted to grow to around USD 11,004.78 million by 2030 with a compound annual growth rate (CAGR) of roughly 4.22% between 2023 and 2030.
Cattle healthcare refers to the measures undertaken to ensure the well-being of cattle. It is similar to human healthcare as it deals with the use of vaccinations and medicines to treat medical conditions in cattle and prevent them from contracting serious or dangerous diseases. Cattle belong to the subfamily Bovinae. In most cases, they are domesticated by humans for varying reasons. The male members of the cattle group are called bulls while the female cattle are called cows. The modern cattle industry is more commercially oriented since cattle are domesticated with the view of achieving certain economic benefits from products derived using cattle.
For instance, they may be used for producing milk which in turn is consumed by humans in various forms or they may be domesticated as livestock for deriving meat. Apart from the food & beverage industry, castles also have other applications including farming in certain countries and use as riding animals. Cattle form an integral part of the biological food ecosystem and hence there is a growing demand for improving cattle healthcare infrastructure. The consequential support of the regional government to create stringent rules promoting cattle medical care defines that the importance of the global cattle healthcare industry is growing steadily.
Growing number of medical cases harming cattle to drive market growth
The global cattle healthcare market is expected to grow owing to the increasing number of medical cases across the globe that are impacting the well-being of cattle. Certain diseases are extremely dangerous leading to deaths or severe malnutrition. The cattle industry is one of the largest contributors to the global economy since products derived from them have extensive applications in end-user industries such as food & beverages and consumer goods. However, the growing number of medical cases greatly affects the overall number of cattle worldwide. For instance, India recently registered a high number of cattle deaths caused by lumpy skin disease (LSD). The condition was not restricted to a certain region but had spread across the country. More than 200,000 castles died between 2022 and 2023 as per official reports.
In December 2023, it was reported that the country was working on developing a new standard operating protocol (SOP) with higher efficiency in stopping the spread of the disease. In October 2023, Europe reported the spread of the deadly Bluetongue virus (BTV). It is spreading across the country rapidly leading to cattle falling severely sick. BTV is caused by midges. The Netherlands region is already witnessing the impact of the virus since the condition does not have any cure or vaccine as of now leading to an urgent demand for improved cattle healthcare structure.
Increased investments in developing new veterinary clinics with advanced facilities to create higher demand
As the cattle population continues to rise, investments in developing large-scale functional and robust veterinary clinics are also surging rapidly across the globe. It includes investments that are aided by the government as well as private cattle healthcare providers.
In December 2023, the New York area in the US witnessed the approval of funds needed to launch a new vet center that will be accessible 24 hours every day in the Rochester area. Another development that indicates the growing status of the global cattle healthcare market is the construction at Keele University of a 24-hour veterinary teaching hospital.
High cost of treatment and lack of knowledge to restrict market growth
The cattle healthcare industry is projected to be restricted due to the high cost of medical treatment associated with cattle care. For instance, as per research, the treatment cost of milk fever, which is related to suboptimal levels of blood calcium in cattle, may be as high as USD 150 per case.
Furthermore, if the condition is more serious or requires surgical intervention, the cost may go even higher. In addition to this, cattle owners may not be aware of medical issues faced by cattle. The lack of knowledge can severely impact the market growth rate during the forecast period.
A growing number of companies providing medical insurance for cattle hold excellent growth opportunities
The global cattle healthcare market is projected to further grow during the coming years as more companies providing medical insurance for cattle are steadily emerging in the overall animal care industry. Access to medical insurance provides a sense of relief to cattle owners and breeders, especially in areas with high costs of medical care for cattle.
In April 2023, Agricultural Insurance Company of India Ltd (AIC) and the Kerala Cooperative Milk Marketing Federation (Milma) signed a memorandum of understanding (MoU) as the firms plan to introduce cattle insurance under a new scheme titled Saral Krishi Bima. The initiative will cover buffaloes and cows against medical issues.
Increased initiatives by the government to promote cattle care may allow more avenues for higher growth
The regional governments are increasingly working toward ensuring that the cattle industry survives in the long run due to the high importance it holds in the global economic world. In addition to this, there have been several positive developments in terms of international collaboration to improve cattle healthcare.
For instance, in May 2023, the Australian government supplied more than 500,000 thousand vaccination doses to Indonesia as the country was trying to manage the spread of LSD. The global cattle healthcare market may further be helped by the increasing demand from consumers for transparent information on cattle origin since people are at a greater risk of being affected by diseases caused by consuming meat.
Lack of efficient infrastructure and skilled veterinarians to challenge market growth
The global industry for cattle healthcare is projected to be impacted by the lack of an efficient infrastructure that promotes equal access to high-grade cattle healthcare. While certain countries boast of a robust architecture, there are a large number of nations that do not enjoy the same supporting environment. Additionally, there is a significant gap in the supply and demand for skilled professionals adding to the growth barrier.
The global cattle healthcare market is segmented based on end-user, product, and region.
Based on end-user, the global market is segmented into veterinary hospitals, dairy farms, and others. In 2022, the highest growth was registered in the veterinary hospitals segment. These facilities are equipped to handle all types of cattle-related medical conditions including surgical procedures. Additionally, the increasing number of veterinary centers and schools globally further contributes to segmental growth. Dairy farms are essential to the overall growth since the global dairy industry is one of the fastest-growing industries worldwide. In 2022, the dairy sector was valued at over USD 894 billion and is projected to cross USD 1 trillion by 2030.
Based on product, the global market is divided into pain management, vaccines, nutritious food, and antibiotics. In 2022, the most significant revenue-generating segment was nutritious food. It is the primary method of ensuring cattle's well-being. The demand for vaccines was higher in 2022 as compared to 2021 as a result of the surging number of cattle being affected by the lumpy skin disease. The most common vaccine for cattle is Blackleg or Clostridium chauvoei. Cattle between the ages of 6 to 24 months are most vulnerable to the infection. Pain management is a crucial step in surgical scenarios.
Report Attributes | Report Details |
---|---|
Report Name | Cattle Healthcare Market |
Market Size in 2022 | USD 7,905.45 Million |
Market Forecast in 2030 | USD 11,004.78 Million |
Growth Rate | CAGR of 4.22% |
Number of Pages | 224 |
Key Companies Covered | Merck Animal Health, Zoetis, Ceva Santé Animale, Boehringer Ingelheim, IDEXX Laboratories, Elanco Animal Health, Norbrook Laboratories, Bayer Animal Health, Huvepharma, Virbac, Dechra Pharmaceuticals, Vetoquinol, Neogen Corporation, Bimeda Inc., Phibro Animal Health Corporation, and others. |
Segments Covered | By End-User, By Product, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2023 - 2030 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Europe to register the highest growth rate during the forecast period
The global cattle healthcare market will be led by Europe during the projection period. The countries in the European Union have extensive and stringent laws supporting animal welfare and medical care. For instance, Austria is regarded as one of the leading nations with forward-looking regulations for animal care. As per the Austrian Animal Welfare Act 2004, animal welfare is regarded as equal to human welfare in the country. Other nations such as the United Kingdom and Switzerland also contribute to regional revenue. The presence of a commercially successful livestock industry as well as the growing use of cattle-derived products across regional industries further contributes to regional growth rate.
Asia-Pacific is a fast-growing region. India, China, Japan, and other countries are essential contributors. In March 2023, Japan Vietnam Livestock Co., Ltd. launched the largest cattle farm in Vietnam along with massive beef processing complexes. Japan Vietnam Livestock Co., Ltd. is a collaboration between Vietnam Livestock Corporation JSC and Sojitz Corporation. The growing consumption of a meat-based diet as well as the surging daily sector along with favorable government policies aid regional expansion.
The global cattle healthcare market is led by players like:
By End-User
By Product
FrequentlyAsked Questions
Cattle healthcare refers to the measures undertaken to ensure the well-being of cattle
The global cattle healthcare market is expected to grow owing to the increasing number of medical cases across the globe that are impacting the well-being of cattle.
According to study, the global cattle healthcare market size was worth around USD 7,905.45 million in 2022 and is predicted to grow to around USD 11,004.78 million by 2030.
The CAGR value of cattle healthcare market is expected to be around 4.22% during 2023-2030.
The global cattle healthcare market will be led by Europe during the projection period.
The global cattle healthcare market is led by players like Merck Animal Health, Zoetis, Ceva Santé Animale, Boehringer Ingelheim, IDEXX Laboratories, Elanco Animal Health, Norbrook Laboratories, Bayer Animal Health, Huvepharma, Virbac, Dechra Pharmaceuticals, Vetoquinol, Neogen Corporation, Bimeda Inc., and Phibro Animal Health Corporation among others.
The report explores crucial aspects of the cattle healthcare market including detailed discussion of existing growth factors and restraints while also browsing future growth opportunities and challenges that impact the market.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed